Atlas Trials

Phase III Study With Idebenone in Patients With Duchenne Muscular Dystrophy (SIDEROS-E)

Clinical trial NCT03603288 · TERMINATED

Trial details

NCT number
NCT03603288
Sponsor
Santhera Pharmaceuticals
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Duchenne Muscular Dystrophy
Start date
2018-07-04
Primary completion
2020-11-25
Enrollment
161

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.